Join
Live feed
·
INSIDERFilingvia Quantisnow
NGM Biopharmaceuticals Inc. logo

Goeddel David V returned 22,008,593 shares to the company and acquired 1,000 shares, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NGM· NGM Biopharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NGM (NGM Biopharmaceuticals Inc.) and more on Quantisnow.